Sort
39,280 grants matching “leukemia”
The Role of NOTCH1 in the Pathogenesis of CLL.
$358,315Riccardo Dalla-Favera · Columbia University Health Sciences · R01 · FY2017 · CA
Enabling Technologies for hES Cell Self-Renewal
$358,222Kevin E Healy · University Of California Berkeley · R01 · FY2011 · HL
Cloning of the vic1 gene, a novel retrovirus restriction factor
$358,202Tatyana V. Golovkina · University Of Chicago · R01 · FY2010 · CA
Investigating novel synthetic lethal epigenetic interactions in Acute Myeloid Leukemia
$358,194Junwei Shi · University Of Pennsylvania · R01 · FY2024 · CA
INTERACTION OF NOTCH WITH THE ABL SIGNALING PATHWAY
$358,172Fred Hutchinson Cancer Research Center · R01 · FY2001 · GM
Adapter molecules on C3a receptor signaling in mast cells
$358,125Hydar Ali · University Of Pennsylvania · R56 · FY2009 · AI
Biomarkers of Benzene Exposure and Genotoxicity
$358,125University Of California Berkeley · R01 · FY2004 · ES
Engineered CD4 Tregs Targeting B-ALL and AML
$358,118John E Wagner · University Of Minnesota · P01 · FY2025 · CA
Vector Integration and Tracking
$358,108Brian C Beard · Seattle Children'S Hospital · P01 · FY2014 · AI
Biomarkers of Benzene Exposure and Genotoxicity
$358,068University Of California Berkeley · R01 · FY2005 · ES
Quantifying phenotypic adaptation of biological systems in dynamic environments
$358,063Jason George · Texas Engineering Experiment Station · R35 · FY2024 · GM
Mechanism(s) of TAL1-and NOTCH1-mediated Leukemogenesis
$358,031Michelle Alice Kelliher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2017 · CA
Mechanism(s) of TAL1-and NOTCH1-mediated Leukemogenesis
$358,031Michelle Alice Kelliher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2016 · CA
Mechanism(s) of TAL1-and NOTCH1-mediated Leukemogenesis
$358,031Michelle Alice Kelliher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2018 · CA
Mechanism(s) of TAL1-and NOTCH1-mediated Leukemogenesis
$358,031Michelle Alice Kelliher · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · CA
The Immunobiology of Marrow Allografts for Leukemia
$358,014Sloan-Kettering Institute For Cancer Res · P01 · FY2004 · CA
Pleiotrophin, a paracrine regulator of hematopoietic stem cell fate
$358,013John P Chute · University Of California Los Angeles · R01 · FY2016 · HL
Therapeutic targeting of MicroRNA-21 in Myelodysplastic syndromes
$358,005Amit Verma · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · DK
Therapeutic targeting of MicroRNA-21 in Myelodysplastic syndromes
$358,005Amit Verma · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · DK
Tolerogenic DC as Therapeutic Agents in GVHD
$358,000Eugene C Butcher · Palo Alto Veterans Instit For Research · R01 · FY2010 · AI
Tolerogenic DC as Therapeutic Agents in GVHD
$358,000Eugene C Butcher · Palo Alto Veterans Instit For Research · R01 · FY2009 · AI
Signal-dependent Phosphorylation and Function of IKKy
$357,938Dean Ballard · Vanderbilt University · R01 · FY2007 · AI
Activating PTPN11 and c-kit Mutations in Myeloproliferative Disorder
$357,938Rebecca J Chan · Indiana University Indianapolis · R01 · FY2008 · HL
Validating Syk as a Target for AML Therapy
$357,937Kimberly Stegmaier · Dana-Farber Cancer Inst · R01 · FY2009 · CA
Establishment of Specific Pathogen Free Rhesus Macaques Colonies (U42)
$357,926Gregory Brion Timmel · Oregon Health & Science University · U42 · FY2016 · OD